Boston Scientific (BSX) Reports In-Line Prelim. Q4 Sales

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. GOOGL
5. SPY
6. RMR
7. TSM
8. SPCX
9. DVN
10. CRGY

Go back to Boston Scientific (BSX) Reports In-Line Prelim. Q4 Sales

Boston Scientific Announces Preliminary Unaudited Sales for the Fourth Quarter and Full Year 2018

January 8, 2019 6:30 AM EST

MARLBOROUGH, Mass., Jan. 8, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE:  BSX) generated sales, based upon preliminary unaudited financial information, of approximately $2.56 billion during the fourth quarter of 2018. This represents growth of approximately 6.3 percent on a reported basis, approximately 8.2 percent on an operational1 basis and approximately 7.0 percent on an organic2 basis, all compared to the prior year period.

... More